vimarsana.com

Page 5 - ஆதரவு மூலதனம் நிறுவனம் ஆராய்ச்சி துறை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Aegis Capital Corp acted as Sole Bookrunner on a $8 4 Million Follow-On Offering for Medigus (NASDAQ: MDGS)

Aegis Capital Corp. acted as Sole Bookrunner on a $8.4 Million Follow-On Offering for Medigus (NASDAQ: MDGS) About Medigus Medigus and its subsidiaries are focused on medical-related devices and products and on internet and other online-related technologies. Medical related activities include miniaturized imaging equipment through Scoutcam Inc. (formerly known as Intellisense Solutions Inc.), innovative surgical devices with direct visualization capabilities for the treatment of Gastroesophageal Reflux Disease (GERD) using Medigus Ultrasonic Surgical Endostapler, or MUSE, and biological gels to protect patients against biological threats and prevent intrusion of allergens and viruses through the upper airways and eye cavities through a stake and licensing arrangement with Polyrizon Ltd. Internet-related activities include ad-tech operations through a stake in Gix Internet Ltd., f/k/a Algomizer Ltd., or Gix, and its subsidiary, Linkury Ltd. Medigus also entered into agreements to ac

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.